• 

  Scripps Research Adds New Faculty To World-Class Institute

  One new assistant and one new associate professor to join the institute’s La Jolla and Jupiter campuses, respectively.

• 

  Scripps Research Ranks No. 1 in Innovation Influence

  Annual Nature Index supplement ranks research institutes on influence over scientific patents.

• 

  The Scripps Research Institute and ShangPharma Innovation Announce Translational Research Collaboration

  World-class research institute and new innovation center partner to accelerate early translational research.

• The Scripps Research Institute Appoints Alexandria Real Estate Equities, Inc. CEO Joel Marcus to Board of Directors

  "Joel’s professional experience and business leadership add to the expertise of our current board members."

• 

  Scientific Trailblazers to Address Historic Graduating Class at TSRI

  Scripps Research Graduate Program Marks 25th Commencement with Two Honorary Degree Recipients

• HitGen Announces Drug Discovery Collaboration with the Scripps Research Institute and the California Institute for Biomedical Research (Calibr)

  Leaders in basic and translational research at TSRI and Calibr will provide target materials and relevant know‐how to prosecute drug targets of interest.

• The Scripps Research Institute (TSRI) Expands New Board of Directors with the Appointment of Yucaipa Companies Founder and Philanthropist Ron Burkle

  Burkle is Founder and Chairman of the Ronald W. Burkle Foundation, whose mission is to positively influence people around the world and their communities.

• 

  Philip Dawson Named Dean of The Scripps Research Institute’s Graduate Program

  Dawson brings to his new role more than 25 years’ experience at Scripps Research as a student, alumnus, faculty member and associate dean.

• The Scripps Research Institute Announces New Board Members and Chairman of the Board

  Scripps Research, one of the world's largest, private, non-profit research organizations, today announced the appointment of nine new members to its Board of Directors.

• 

  The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology

  The Scripps Research Institute (TSRI), a leading non-profit biomedical research institute, today announced a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to pioneer new DNA-encoded library (DEL) technology.